InsidersTradesSigma
Track the OCULAR THERAPEUTIX, INC. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was disclosed on 31 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: DONALD D NOTMAN JR.. The full history is free.
Analysts rate OCULAR THERAPEUTIX, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$62.05.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
OCULAR THERAPEUTIX, INC. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos innovadores para enfermedades oculares. Cotiza en el NASDAQ bajo el símbolo OCUL.